Congress bans asbestos, but carves out industrial loopholes until 2036

What it does

This bill bans the manufacture, processing, use, and distribution of commercial asbestos and products containing it, effective immediately upon enactment. It carves out narrow exceptions: chlor-alkali facilities (which use asbestos diaphragms in chemical production) get until 2032 to phase out, with a potential extension to 2036 for operators who convert to non-asbestos technology; sheet gaskets follow existing EPA phase-out timelines; the President may grant one-time 3-year national-security exemptions; and metal ore mining is unaffected. The bill does not apply to asbestos present only as an impurity or to cosmetic regulation.

Why we flagged it

The bill's core function is a comprehensive prohibition on commercial asbestos, a known human carcinogen, with narrow industrial and national-security carve-outs. This is straightforward public-health regulation, not a market intervention or corporate giveaway.

What the text implies

• The chlor-alkali exemption extends asbestos use in industrial chemical production until 2032–2036, potentially delaying full elimination of occupational exposure in that sector by up to a decade.
• The national-security exemption grants the President broad discretion to override the ban for up to 6 years (initial 3-year term plus one 3-year extension) with minimal public disclosure if national-security harm is claimed, creating a potential loophole for sensitive military or aerospace applications.

The full analysis lists 4 implications of this text.

Who stands to gain

asbestos substitutes manufacturers; industrial equipment makers transitioning to non-asbestos diaphragms; environmental remediation and abatement contractors